Ensign Peak Advisors Inc Takes Position in Mirion Technologies, Inc. (NYSE:MIR)

Ensign Peak Advisors Inc bought a new stake in shares of Mirion Technologies, Inc. (NYSE:MIR) during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm bought 472,221 shares of the company’s stock, valued at approximately $8,240,000.

Other institutional investors have also recently modified their holdings of the company. Vanguard Group Inc. boosted its holdings in Mirion Technologies by 1.0% in the 4th quarter. Vanguard Group Inc. now owns 23,909,802 shares of the company’s stock worth $417,226,000 after buying an additional 227,178 shares during the last quarter. T. Rowe Price Investment Management Inc. boosted its holdings in Mirion Technologies by 1.1% in the 4th quarter. T. Rowe Price Investment Management Inc. now owns 20,388,146 shares of the company’s stock worth $355,774,000 after buying an additional 216,258 shares during the last quarter. Dimensional Fund Advisors LP boosted its holdings in Mirion Technologies by 2.5% in the 4th quarter. Dimensional Fund Advisors LP now owns 7,185,694 shares of the company’s stock worth $125,391,000 after buying an additional 171,918 shares during the last quarter. Geode Capital Management LLC boosted its holdings in Mirion Technologies by 1.5% in the 4th quarter. Geode Capital Management LLC now owns 4,571,828 shares of the company’s stock worth $79,796,000 after buying an additional 69,373 shares during the last quarter. Finally, Arrowstreet Capital Limited Partnership boosted its holdings in Mirion Technologies by 29,948.6% in the 4th quarter. Arrowstreet Capital Limited Partnership now owns 4,214,921 shares of the company’s stock worth $73,550,000 after buying an additional 4,200,894 shares during the last quarter. 78.51% of the stock is currently owned by institutional investors and hedge funds.

Mirion Technologies Stock Performance

NYSE:MIR opened at $16.96 on Tuesday. The company has a fifty day simple moving average of $14.65 and a two-hundred day simple moving average of $15.77. The company has a market cap of $3.93 billion, a price-to-earnings ratio of -89.26 and a beta of 0.74. The company has a quick ratio of 1.55, a current ratio of 2.16 and a debt-to-equity ratio of 0.43. Mirion Technologies, Inc. has a 52 week low of $9.11 and a 52 week high of $18.81.

Mirion Technologies (NYSE:MIR) last issued its earnings results on Tuesday, April 29th. The company reported $0.10 EPS for the quarter, topping analysts’ consensus estimates of $0.08 by $0.02. The firm had revenue of $202.00 million during the quarter, compared to the consensus estimate of $199.34 million. Mirion Technologies had a negative net margin of 4.21% and a positive return on equity of 4.78%. The company’s revenue was up 4.9% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.06 earnings per share. As a group, equities analysts anticipate that Mirion Technologies, Inc. will post 0.39 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

Several equities research analysts recently issued reports on the company. B. Riley lowered their price objective on Mirion Technologies from $19.00 to $17.00 and set a “buy” rating on the stock in a report on Wednesday, April 16th. Robert W. Baird lowered their target price on Mirion Technologies from $22.00 to $20.00 and set an “outperform” rating on the stock in a report on Friday, April 4th. Finally, Citigroup lowered their target price on Mirion Technologies from $20.00 to $17.00 and set a “buy” rating on the stock in a report on Monday, April 14th. Four research analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat.com, Mirion Technologies presently has a consensus rating of “Buy” and an average price target of $18.75.

Mirion Technologies Profile

Mirion Technologies, Inc provides radiation detection, measurement, analysis, and monitoring products and services in the United States, Canada, the United Kingdom, France, Germany, Finland, China, Belgium, Netherlands, Estonia, South Korea, and Japan. It operates through two segments, Medical and Technologies.